Filing Details
- Accession Number:
- 0001104659-22-070674
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-06-13 21:07:47
- Reporting Period:
- 2022-06-10
- Accepted Time:
- 2022-06-13 21:07:47
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1504776 | Warby Parker Inc. | WRBY | Ophthalmic Goods (3851) | 800423634 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1883325 | Clive Steven Miller | C/O Warby Parker Inc., 233 Spring Street, 6Th Floor East New York NY 10013 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Acquisiton | 2022-06-10 | 12,137 | $0.00 | 170,506 | No | 4 | M | Direct | |
| Class A Common Stock | Disposition | 2022-06-10 | 5,084 | $14.64 | 165,422 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2022-06-13 | 7,053 | $13.42 | 158,369 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Class A Common Stock | Restricted Stock Units | Disposition | 2022-06-10 | 1,981 | $0.00 | 1,981 | $0.00 |
| Class A Common Stock | Restricted Stock Units | Disposition | 2022-06-10 | 2,525 | $0.00 | 2,525 | $0.00 |
| Class A Common Stock | Restricted Stock Units | Disposition | 2022-06-10 | 2,535 | $0.00 | 2,535 | $0.00 |
| Class A Common Stock | Restricted Stock Units | Disposition | 2022-06-10 | 5,096 | $0.00 | 5,096 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 21,131 | No | 4 | M | Direct | ||
| 16,833 | No | 4 | M | Direct | ||
| 6,759 | No | 4 | M | Direct | ||
| 64,547 | No | 4 | M | Direct |
Footnotes
- Includes 925 shares acquired on May 14, 2022 under the Issuer's employee stock purchase plan in an exempt transaction pursuant to Rule 16b-3(c).
- These share sales are required by the Issuer's equity compensation plan to cover taxes due on restricted stock units ("RSUs") that vested.
- The sales reported were effected pursuant to a 10b5-1 trading plan adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.13 to $14.04. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- Each RSU represents a contingent right to receive one share of the Company's Class A Common Stock.
- This filing relates to the occurrence of a RSU vesting event.
- The RSUs will vest in 48 monthly installments beginning on January 1, 2021 and will expire on January 27, 2028.
- The RSUs will vest in 48 monthly installments beginning on January 1, 2020 and will expire on November 19, 2026.
- The RSUs will vest in 48 monthly installments beginning on January 1, 2019 and will expire on March 28, 2026.
- The RSUs will vest in 48 monthly installments beginning on July 1, 2021 and will expire on June 14, 2031.
Billionaire Hedge Funds
